You are here: Home » Current Affairs » Coronavirus » News
Business Standard

Children, adults produce different antibodies against Covid-19: Study

Children and adults produce different types of antibodies in response to the novel coronavirus, according to a study which suggests the course of infection and immune response is distinct in kids

Medical Research | Coronavirus

Press Trust of India  |  New York 

Coronavirus, covid, tests

Children and adults produce different types and amounts of antibodies in response to the novel infection, according to a study which suggests the course of the infection and immune response is distinct in kids, and most of them easily clear the virus from their bodies.

"Our study provides an in-depth examination of SARS-CoV-2 antibodies in kids, revealing a stark contrast with adults," said Donna Farber, an immunologist at Columbia University in the US.

Matteo Porotto, associate professor at Columbia University said the infectious course in children is much shorter and probably not as disseminated as in adults.

"Kids may clear this virus more efficiently than adults and they may not need a strong antibody immune response to get rid of it," said Poroto, who co-led the study published on Thursday in the journal Nature Immunology.

Among the 47 children in the study, 16 were treated at Columbia University for Multisystem inflammatory syndrome in children (MIS-C) and 31 kids of similar ages had tested positive for the virus after visiting the medical center for the treatment of other conditions. Half of the children without MIS-C had no COVID-19 symptoms.

The 32 adults in the study ranged from severely affected patients admitted to the hospital to those with milder disease who recovered at home, the researchers said.

Both groups of children produced the same antibody profile, the study found, which differed from that of adults.

Compared with adults, children produced fewer antibodies against the virus's spike protein -- which the virus uses to infect human cells, according to the researchers.

The children's antibodies had the least neutralising activity, while all adults, including young adults in their 20s, produced neutralising antibodies. The sickest adults had the most neutralising activity, they said.

Though it may seem counterintuitive that the sickest patients produce antibodies with the greatest neutralising activity, Farber said that likely reflects the amount of time the virus is present in the sickest patients.

"There is a connection between the magnitude of your immune response and the magnitude of the infection: The more severe the infection, the more robust the immune response, because you need to have more immune cells and immune reactions to clear a higher dose of a pathogen," he added.

In contrast to adults, children also produced very few antibodies against a viral protein that is only visible to the immune system after the virus infects human cells, the researchers said.

"That suggests that in kids, the infection doesn't really spread a lot and doesn't kill a lot of their cells," Farber said.

"Because children clear the natural virus rapidly, they do not have a widespread infection and they do not need a strong antibody response," Porotto added.

The reduced course of infection in children may signify that they are infectious for a shorter period of time compared with adults and therefore less likely to spread the virus, although the researchers did not measure viral load in the children.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

Dear Reader,

Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

First Published: Fri, November 06 2020. 18:26 IST